Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Piramal | Healthcare

Pharma Solutions is the contract development and manufacturing (CDMO) division of Piramal | Healthcare, a part of the Piramal Enterprise. We are one of the largest custom manufacturing companies in the world that provides flexibility and scalability of operations. We have created a vast network of contract development and manufacturing facilities located in North America, Europe and Asia that offers a multitude of services that cover the entire drug-cycle, from development and commercial manufacturing to off-patent supplies of Active Pharmaceutical Ingredients (APIs) and formulations. Our network enables us to deliver benefits by strategically placing projects to take advantage of low costs, local supply chains and specific customer/ market requirements. This division features among the top 10 contract drug manufacturers in the world.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Piramal | Healthcare
247 Business Park, A - Wing, 6th Floor, LBS Marg, Vikhroli (West), Mumbai, Maharashtra, 400083, India
022-30956893
Contact Piramal | Healthcare
Website

 Latest Content from PMHub 

Episode 1: Patient Centricity on Trial – Claire Knapp and Mark Evans, Havas Lynx Group, Keynote

Videos and Podcasts | July 19, 2019 | Havas Lynx

Elizabeth Egan appointed President of Havas Lynx Group

Press Releases | July 19, 2019 | Havas Lynx

Europe’s largest healthcare communications agency has appointed a new President to help it build on a record year.

We are Gold! Porterhouse Medical Group is recognised as an ‘Investor in People’ at the Gold level

Press Releases | July 17, 2019 | Porterhouse Medical Group

Porterhouse Medical Group is delighted to announce that we have been awarded the Investors in People (IIP) accreditation at the Gold level, demonstrating our commitment to realising the potential of...

Bluedog is bursting with new creative and digital talent

Press Releases | July 15, 2019 | Lucid Group Communications Limited

Bluedog, a Lucid Group company, welcomes four spellbinding new additions to its team.With a strong background in animation, Rachel Sparks joins Bluedog as a motion designer. Having previously worked in...

Precision paediatrics: Treating patients with CAR-T

White Papers and Resources | July 12, 2019 | Blue Latitude Health

Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...

What does it mean to be an agile organisation

White Papers and Resources | July 11, 2019 | Blue Latitude Health

We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market.

Battling breast cancer with precision medicine (Part 2)

White Papers and Resources | July 10, 2019 | Blue Latitude Health

Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Corporate event food. How to get it right

Press Releases | July 10, 2019 | Apex Events and Exhibitions

Food affects our mood. When we are hungry, we are more likely to be irritable and unhappy. On the other hand, being full makes us happy and relaxed. But, with...

How patient insights were brought to life with graphic novel outputs

White Papers and Resources | July 10, 2019 | Inizio

Research Partnership's client was developing a novel therapy for the treatment of a rare disease in which patients suffer acute symptomatic attacks; the main burden of disease is not just...

Research Partnership publishes new patient Living with Ankylosing Spondylitis & nr-axSpA EU & US 2019 reports

White Papers and Resources | July 10, 2019 | Inizio

Living with Ankylosing Spondylitis (AS) & nr-AxSpA are reports based on quantitative studies conducted online in the 5EU and US. The AS 5EU report comprises of interviews with 385 patients...